APA

Yanny B., Saab S., Durazo F., Latt N., Mitry A., Mikhail M. M., Hanna R. M., Aziz A. & Sahota A. (20190411). Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. : Digestive diseases and sciences.

Chicago

Yanny Beshoy, Saab Sammy, Durazo Francisco, Latt Nyan, Mitry Amanda, Mikhail Mira Moris, Hanna Ramy M, Aziz Antony and Sahota Amandeep. 20190411. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. : Digestive diseases and sciences.

Harvard

Yanny B., Saab S., Durazo F., Latt N., Mitry A., Mikhail M. M., Hanna R. M., Aziz A. and Sahota A. (20190411). Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. : Digestive diseases and sciences.

MLA

Yanny Beshoy, Saab Sammy, Durazo Francisco, Latt Nyan, Mitry Amanda, Mikhail Mira Moris, Hanna Ramy M, Aziz Antony and Sahota Amandeep. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. : Digestive diseases and sciences. 20190411.